Interferon Alpha Treatment of Patients with Impaired Interferon Gamma Signaling
Authors:
- 20 March 2013
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 33 (5) , 991-1001
Abstract
Patients with deficiency in the interferon gamma receptor (IFN-γR) are unable to respond properly to IFN-γ and develop severe infections with nontuberculous mycobacteria (NTM). IFN-γ and IFN-α are known to signal through STAT1 and activate many downstream effector genes in common. Therefore, we added IFN-α for treatment of patients with disseminated mycobacterial disease in an effort to complement their IFN-γ signaling defect. We treated four patients with IFN-γR deficiency with adjunctive IFN-α therapy in addition to best available antimicrobial therapy, with or without IFN-γ, depending on the defect. During IFN-α treatment, ex vivo induction of IFN target genes was detected. In addition, IFN-α driven gene expression in patients’ cells and mycobacteria induced cytokine response were observed in vitro. Clinical responses varied in these patients. IFN-α therapy was associated with either improvement or stabilization of disease. In no case was disease exacerbated. In patients with profoundly impaired IFN-γ signaling who have refractory infections, IFN-α may have adjunctive anti-mycobacterial effects.Keywords
This publication has 43 references indexed in Scilit:
- Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 DeficiencyScience, 2012
- Inborn Errors of Human JAKs and STATsImmunity, 2012
- Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis InfectionImmunity, 2011
- Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindredsHuman Molecular Genetics, 2011
- Type I interferon: friend or foe?Journal of Experimental Medicine, 2010
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage populationJournal of Clinical Investigation, 2010
- Type I Interferon: A New Player in TNF Signaling2010
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune DiseasesImmunity, 2009
- Interferon‐αβ mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette–Guérin infectionImmunology, 2006